Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

AuthID
 P-00Z-DQE
17
Author(s)
Khan, MS
·
Anker, SD
·
Filippatos, G
·
Pocock, SJ
·
Januzzi, JL
·
Chopra, VK
·
Piña, IL
·
Böhm, M
·
Ponikowski, P
·
Verma, S
·
Brueckmann, M
·
Vedin, O
·
Peil, B
·
Zannad, F
·
Packer, M
·
Butler, J
Document Type
Article
Year published
2023
Published
in JOURNAL OF CARDIAC FAILURE, ISSN: 1071-9164
Volume: 29, Issue: 10, Pages: 1345-1354 (10)
Indexing
Wos®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 37558088
Wos: WOS:001103175200001
Source Identifiers
ISSN: 1071-9164
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text
Full Text @ sfx.b-on.pt

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service